Ori Biotech and CRL Enhance CAR-T Productionby Lilu Anderson 21.09.2024Ori Biotech and CRL partner to optimize CAR-T production, reducing labor by 70%, costs by 50%, and process time by ...
Medera’s SPAC Merger Marks Rare Biotech Moveby Lilu Anderson 06.09.2024Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
Biotech Funding Steady: Investors Eye Late-Stage Assetsby Lilu Anderson 18.08.2024Biotech sees stable funding as 2024 venture capital and IPOs rise. Investors focus on late-stage assets amid economic challenges.
Top Defensive Biotech Stocks Amid Market Turmoilby Lilu Anderson 10.08.2024Discover Piper Sandler's eight high-quality defensive biotech stocks poised to thrive in volatile markets.
Biotech Stocks to Buy in Market Downturnby Lilu Anderson 08.08.2024Explore top biotech stocks poised for growth amid market challenges. Learn about innovations and opportunities in gene therapy.
Bio-Techne’s Growth Projections Amid Fiscal Challengesby Mark Eisenberg 08.08.2024Bio-Techne shows resilience with strategic growth in diagnostics despite fiscal year challenges and market declines.
Biotech’s Big Gamble Fails: Insights and Implicationsby Lilu Anderson 18.06.2024Catch up on biotech headlines: Zentalis faces FDA hold, Aerovate's major setback, Merck's new vaccine, and promising trials by Intra-Cellular ...
Biotech’s Big Gamble Fails: Insights and Implicationsby Lilu Anderson 18.06.2024Catch up on biotech headlines: Zentalis faces FDA hold, Aerovate's major setback, Merck's new vaccine, and promising trials by Intra-Cellular ...
7 Breakthrough Biotech Stocks to Boost Your Portfolio in 2023by Lilu Anderson 18.06.2024"Discover 7 breakthrough biotech stocks poised to boost your portfolio in a sector projected to reach $521.6B by 2033. Learn ...
Brazil’s Strategic Move to Lower CAR-T Costsby John Darbie 27.03.2024Exciting news from Adam Feuerstein! His informative and spicy newsletter will debut tomorrow. Brazilian government aiming to reduce healthcare costs ...